Sign in

NCT06092554Completed

Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)

Probiotics in ICU to Reduce Ventilator-Associated Pneumonia: A Double-blind Multicentre Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

PROACT study aims to resolve uncertainties to influence actual practice guidelines or public health policing regarding VAP prevention in ICU by using probiotics administration. Multi-trauma patients with a head injury OR stroke or brain haemorrhage patients without any sign of aspiration and lung infection will be enrolled and randomized to either placebo or probiotic treatment to assess if VAP and mortality can be reduced in the interventional group.

Status (registry)
Completed
Study type
Interventional
Enrollment
213 (actual)
First submitted
15 Oct 2023
Start date
13 Dec 2023
Primary completion date
13 Sept 2026
Lead sponsor
University of Bari
Diseases
Stroke
NCT number
NCT06092554

What you commit to

  • Study type: Interventional
  • Participants enrolled: 213
  • From 13 Dec 2023 to the primary completion date, 13 Sept 2026
  • 10 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • has received mechanical ventilation more than 72 hours from start of screening
  • those receiving chronic immunosuppressive medications (e.g., azathioprine, cyclosporine, cyclophosphamide, tacrolimus, methotrexate, mycofenolate, Anti-IL2)
  • previous transplantation at any time
  • inability to receive enteral medications
  • patients at risk of endovascular infection which includes
    • previously documented rheumatic heart disease, congenital valve disease, surgically repaired congenital heart disease, unrepaired cyanotic congenital heart disease, any intracardiac repair with prosthetic material \[mechanical or bioprosthetic cardiac valves\]
    • previous or current endocarditis
    • permanent endovascular devices (e.g., endovascular grafts \[e.g., aortic aneurysm repair, stents involving large arteries such as aorta, femorals and carotids\] inferior vena cava filters, dialysis vascular grafts
    • tunnelled (not short-term) hemodialysis catheters
    • pacemakers or defibrillators
    • Patients with peripherally inserted central catheters (PICCs), temporary central venous catheters, central venous dialysis catheters, coronary artery stents, coronary artery bypass grafts (CABG), or neurovascular coils are not excluded, nor are patients with mitral valve prolapse or bicuspid aortic valve if they do not meet any other exclusion criteria.

Other illness

  • patients at risk of iatrogenic probiotic infection e.g. immunosuppression which includes
  • HIV \<200 CD4 cells/μL
  • malignancy requiring chemotherapy in the last 3 months
  • ischemic bowel disease

Lab values

  • neutropenia \[absolute neutrophil count \< 500\])

Other

  • pregnancy or Lactation
  • patients with a primary diagnosis of severe pancreatitis (Ranson score of 3 or more). Mild and moderate pancreatis is not excluded
  • oropharyngeal mucosal injury
  • intent to withdraw advanced life support as per ICU doctor in charge
  • patients with sepsis and/or septic shock

Who the study is looking for

  • adults aged 18-80 years
  • at least one of the following conditions: a) recent trauma involving head injury and at least one more organ system; b) stroke or brain hemorrhage without any sign of aspiration and lung infection
  • intubation and start of mechanical ventilation. This needs to start immediately after the event described in the inclusion criteria (b). For cases of head trauma this is defined as start in the ambulance or the emergency department
  • likelihood that the duration of mechanical ventilation would be at least six days
  • written informed consent provided by the patient or legal representative

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Erasme
Coordinator of this site? Confirm its status
BrusselsBelgiumUnknown status
Regional General Hospital F. Miulli
Coordinator of this site? Confirm its status
Acquaviva delle FontiItalyUnknown status
Azienda Ospedaliero-Universitaria di Alessandria SS. Antonio e Biagio e Cesare Arrigo
Coordinator of this site? Confirm its status
AlessandriaItalyUnknown status
Ospedale Di Venere
Coordinator of this site? Confirm its status
BariItalyUnknown status
Intensive Care Unit, Policlinico di Bari
Coordinator of this site? Confirm its status
BariItalyUnknown status
AUSL Bologna Ospedale Bellaria
Coordinator of this site? Confirm its status
BolognaItalyUnknown status
Azienda Ospedaliero Universitaria di Parma
Coordinator of this site? Confirm its status
ParmaItalyUnknown status
Azienda Ospedaliera di Perugia
Coordinator of this site? Confirm its status
PerugiaItalyUnknown status
Fondazione IRCCS Casa Sollievo della Sofferenza
Coordinator of this site? Confirm its status
San Giovanni RotondoItalyUnknown status
Azienda Ospedaliera Santa Maria di Terni
Coordinator of this site? Confirm its status
TerniItalyUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.